Joseph Stringer

Stock Analyst at Needham

(1.09)
# 1835
Out of 5,328 analysts
331
Total ratings
34.75%
Success rate
-3.48%
Average return
23 Stocks
Name Action PT Current % Upside Ratings Updated
IONS Ionis Pharmaceutical...
Maintains: Buy
60 55
31.99 71.93% 21 Apr 30, 2025
GILD Gilead Sciences
Reiterates: Hold
n/a
n/a n/a 5 Apr 25, 2025
PHAT Phathom Pharmaceutic...
Reiterates: Buy
28 28
3.15 788.89% 51 Apr 21, 2025
CDTX Cidara Therapeutics
Reiterates: Buy
35 35
21.59 62.11% 10 Apr 10, 2025
RNA Avidity Biosciences
Reiterates: Buy
60 60
32.94 82.15% 17 Apr 9, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
22 22
9.87 122.9% 22 Apr 9, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
320 320
252.64 26.66% 21 Apr 9, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
90 90
35.28 155.1% 17 Apr 8, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
15 15
1.18 1171.19% 18 Apr 8, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
66 66
63.83 3.4% 23 Apr 8, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Hold
n/a
n/a n/a 13 Mar 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
16 16
1.83 774.32% 18 Mar 4, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
10 10
1.62 517.28% 17 Mar 4, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
19 19
6.13 209.95% 16 Feb 27, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Hold
n/a
n/a n/a 5 Feb 11, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Hold
n/a
n/a n/a 8 Nov 8, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
85 60
20.33 195.13% 19 Nov 6, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 16 Jun 13, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
37
14.61 153.25% 5 Jan 24, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 5 May 23, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
42 32
n/a n/a 1 May 13, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 1 Dec 13, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
32 18
10.32 74.42% 2 Aug 24, 2021